Cargando…
N-acetyl cysteine versus allopurinol in the prevention of contrast nephropathy in patients with chronic kidney disease: A randomized controlled trial
Contrast media administration can lead to acute deterioration in renal function particularly in patients with pre-existing chronic kidney disease. This prospective, randomized controlled open-label parallel group study was undertaken at Nizam's Institute of Medical Sciences, Hyderabad, from Jun...
Autores principales: | Sadineni, R., Karthik, K. R., Swarnalatha, G., Das, U., Taduri, G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5358166/ https://www.ncbi.nlm.nih.gov/pubmed/28356658 http://dx.doi.org/10.4103/0971-4065.194397 |
Ejemplares similares
-
Comparison of Oral and Intravenous N-acetyl Cysteine in Preventing Contrast Nephropathy
por: Khatami, Mohammad Reza, et al.
Publicado: (2020) -
Allopurinol for prevention of progression of kidney disease with hyperuricemia
por: Pai, B. H. Santhosh, et al.
Publicado: (2013) -
Effect of N-acetyl cysteine in prevention of contrast nephropathy on patients under intravenous pyelography and contrast CT
por: Momeni, Ali, et al.
Publicado: (2012) -
Comparing Trimetazidine with Allopurinol in Prevention of Contrast Induced Nephropathy After Coronary Angiography
por: Galal, Haitham, et al.
Publicado: (2020) -
A Case of Joubert Syndrome with Chronic Kidney Disease
por: Shamsudheen, M. P., et al.
Publicado: (2021)